Navigation Links
NDI Announces New Healthcare Venture Fund

CLEVELAND, Jan. 31, 2011 /PRNewswire/ -- NDI has launched the NDI Healthcare Fund, a new commercialization fund focused on developing innovative neurodevice technologies.  The Fund recently raised $8 million from equity investments and a grant from the State of Ohio.


"The NDI Healthcare Fund will invest in both seed-stage neurodevice companies and technologies," said Geoff Thrope, NDI's CEO, founder and president. "We are looking for product opportunities in large markets where there is at least one validated product, but where critical clinical needs still exist."

NDI is a leader in commercializing innovative neurodevice technologies to address significant unmet health conditions, improve patients' lives, and provide significant returns to investors.  Over the past decade, NDI's team of neurodevice entrepreneurs, scientists and professionals has developed products to restore lost neurological function, prevent damage, and reduce the effects of disease and injury.  

In April 2008, NDI sold its MEDSTIM urinary incontinence system to Medtronic for $42 million.  

Since then, the company has raised an additional $15 million in private equity and another $7 million in grants and loans from the State of Ohio's Third Frontier Program and the NIH.  

NDI invests these funds in its unique platform of technologies, pipeline of commercialization opportunities, and portfolio companies, including Checkpoint Surgical and SPR™ Therapeutics.  

Checkpoint Surgical provides physicians with medical devices to locate, evaluate and preserve nerves and muscles in surgical procedures for better patient outcomes. SPR™ Therapeutics is developing patented nerve stimulation products for treating chronic and severe pain.

NDI maintains core capabilities under one roof -- including clinical and regulatory affairs, engineering and product development, operations and research -- to assess, develop and generate neurodevice products and companies. NDI is headquartered in Cleveland, Ohio, one of the world's leading centers of neurodevice research and innovation.

For more information on NDI, please contact Jackie Greiner at (216) 378-9106, ext. 117 or email at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests
2. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
3. Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
4. Endologix Announces Favorable Clinical Results for Nellix Technology
5. Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II
6. Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments
7. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
8. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
9. Physiotherapy Associates Announces New Clinic in Castle Rock, CO
10. Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results
11. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
Post Your Comments:
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):